Search

Paul E. Zarek

Examiner (ID: 16775)

Most Active Art Unit
1628
Art Unit(s)
1628, 4161, 1617
Total Applications
773
Issued Applications
369
Pending Applications
1
Abandoned Applications
407

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8270402 [patent_doc_number] => 08211905 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-07-03 [patent_title] => 'Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties' [patent_app_type] => utility [patent_app_number] => 12/423641 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 28068 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12423641 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/423641
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Apr 13, 2009 Issued
Array ( [id] => 5474470 [patent_doc_number] => 20090247636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'AGENT FOR SUPPRESSION OF GASTRIC EMPTYING COMPRISING 4-HYDROXYISOLEUCINE' [patent_app_type] => utility [patent_app_number] => 12/422488 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3699 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247636.pdf [firstpage_image] =>[orig_patent_app_number] => 12422488 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422488
AGENT FOR SUPPRESSION OF GASTRIC EMPTYING COMPRISING 4-HYDROXYISOLEUCINE Apr 12, 2009 Abandoned
Array ( [id] => 5570358 [patent_doc_number] => 20090253736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'AZAINDOLE DERIVATIVES AS CFTR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/422496 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25069 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253736.pdf [firstpage_image] =>[orig_patent_app_number] => 12422496 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422496
Azaindole derivatives as CFTR modulators Apr 12, 2009 Issued
Array ( [id] => 6517853 [patent_doc_number] => 20100261731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate' [patent_app_type] => utility [patent_app_number] => 12/422434 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6552 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261731.pdf [firstpage_image] =>[orig_patent_app_number] => 12422434 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422434
Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate Apr 12, 2009 Abandoned
Array ( [id] => 6516965 [patent_doc_number] => 20100261684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction' [patent_app_type] => utility [patent_app_number] => 12/386008 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1795 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261684.pdf [firstpage_image] =>[orig_patent_app_number] => 12386008 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386008
Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction Apr 12, 2009 Abandoned
Array ( [id] => 5558865 [patent_doc_number] => 20090270442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'POLYMORPHS OF HYDROCHLORIDE SALT OF 5-(3-(ETHYLSULFONYL)PHENYL)-3,8-DIMETHYL-N-(1-METHYLPIPERIDIN-4-YL)-9H-PYRIDO[2,3-B]INDOLE-7-CARBOXAMIDE AND METHODS OF USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/422877 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 33641 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270442.pdf [firstpage_image] =>[orig_patent_app_number] => 12422877 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422877
POLYMORPHS OF HYDROCHLORIDE SALT OF 5-(3-(ETHYLSULFONYL)PHENYL)-3,8-DIMETHYL-N-(1-METHYLPIPERIDIN-4-YL)-9H-PYRIDO[2,3-B]INDOLE-7-CARBOXAMIDE AND METHODS OF USE THEREFOR Apr 12, 2009 Abandoned
Array ( [id] => 6516975 [patent_doc_number] => 20100261686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction' [patent_app_type] => utility [patent_app_number] => 12/384881 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1120 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261686.pdf [firstpage_image] =>[orig_patent_app_number] => 12384881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/384881
Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction Apr 9, 2009 Abandoned
Array ( [id] => 5485781 [patent_doc_number] => 20090275546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Diagnostic tests and personalized treatment regimes for cancer stem cells' [patent_app_type] => utility [patent_app_number] => 12/386002 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15163 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275546.pdf [firstpage_image] =>[orig_patent_app_number] => 12386002 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386002
Diagnostic tests and personalized treatment regimes for cancer stem cells Apr 9, 2009 Abandoned
Array ( [id] => 5374754 [patent_doc_number] => 20090312315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'PAI-1 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/422099 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 232953 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312315.pdf [firstpage_image] =>[orig_patent_app_number] => 12422099 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422099
PAI-1 inhibitor Apr 9, 2009 Issued
Array ( [id] => 9216372 [patent_doc_number] => 08629172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Methods and compositions for treating post-operative pain comprising clonidine' [patent_app_type] => utility [patent_app_number] => 12/421144 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 21509 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12421144 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421144
Methods and compositions for treating post-operative pain comprising clonidine Apr 8, 2009 Issued
Array ( [id] => 5485793 [patent_doc_number] => 20090275558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'SUBSTITUTED SULFONAMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/421230 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55147 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275558.pdf [firstpage_image] =>[orig_patent_app_number] => 12421230 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421230
Substituted sulfonamide compounds Apr 8, 2009 Issued
Array ( [id] => 6547960 [patent_doc_number] => 20100016445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'TRANSDERMAL DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/421471 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016445.pdf [firstpage_image] =>[orig_patent_app_number] => 12421471 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421471
TRANSDERMAL DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER Apr 8, 2009 Abandoned
Array ( [id] => 5570420 [patent_doc_number] => 20090253798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'COLCHICINE SOLID COMPLEX; METHODS OF MAKING; AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/416990 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6207 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253798.pdf [firstpage_image] =>[orig_patent_app_number] => 12416990 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/416990
Colchicine solid complex; methods of making; and methods of use thereof Apr 1, 2009 Issued
Array ( [id] => 5474387 [patent_doc_number] => 20090247553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity' [patent_app_type] => utility [patent_app_number] => 12/411526 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9933 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247553.pdf [firstpage_image] =>[orig_patent_app_number] => 12411526 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/411526
Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity Mar 25, 2009 Abandoned
Array ( [id] => 5474409 [patent_doc_number] => 20090247575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/412029 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16353 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247575.pdf [firstpage_image] =>[orig_patent_app_number] => 12412029 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/412029
STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS Mar 25, 2009 Abandoned
Array ( [id] => 9844380 [patent_doc_number] => 08946297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Solid composition for pest control' [patent_app_type] => utility [patent_app_number] => 12/919428 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3946 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919428 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/919428
Solid composition for pest control Mar 17, 2009 Issued
Array ( [id] => 9551604 [patent_doc_number] => 08758648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Stabilizer of color former and use thereof' [patent_app_type] => utility [patent_app_number] => 12/933569 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11381 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12933569 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/933569
Stabilizer of color former and use thereof Mar 17, 2009 Issued
Array ( [id] => 6136989 [patent_doc_number] => 20110009453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => ' S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/922629 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7205 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009453.pdf [firstpage_image] =>[orig_patent_app_number] => 12922629 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/922629
S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION Mar 15, 2009 Abandoned
Array ( [id] => 9761886 [patent_doc_number] => 08846205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Hybrid strategies for reducing leaching of metal biocides from biodegradable substrates' [patent_app_type] => utility [patent_app_number] => 12/381460 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15240 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12381460 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/381460
Hybrid strategies for reducing leaching of metal biocides from biodegradable substrates Mar 11, 2009 Issued
Array ( [id] => 7687491 [patent_doc_number] => 20090176800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'IN VIVO SCREENING METHOD OF THERAPEUTIC AGENT FOR MEMORY/LEARNING DYSFUNCTIONS BY SCHIZOPHRENIA' [patent_app_type] => utility [patent_app_number] => 12/401958 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5983 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176800.pdf [firstpage_image] =>[orig_patent_app_number] => 12401958 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/401958
Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone Mar 10, 2009 Issued
Menu